Posted in | News | LEDs

Nexxus Lighting Earns Design Patents for Array Lighting LED Products

Nexxus Lighting, Inc. (NASDAQ:NEXS) today announced that it has been issued three new design patents related to its Array™ Lighting LED replacement light bulb product line. US Design Patent No. D600,837 – LIGHT (Par 38); US Design Patent No. D601,276 – LIGHT (Par 30) and US Design Patent No. D601,277 – LIGHT (MR16 G-10) cover the unique fin / air flow design, overall shape and LED configurations of the existing Array™ Par 30 and Array™ MR16 bi-pin and Array™ MR16 with a GU10 pin base lamp as well as the new state-of-the-art Par 38 which is expected to be introduced in 2010.

These designs along with several other patent pending technologies related to the products’ unique “selective heat sink – SHS technology” provide extensive intellectual property coverage for the company’s Array™ Lighting direct replacement LED product line used in commercial lighting applications including down lighting, track lighting, accent lighting and retail display lighting.

Nexxus Lighting now holds a total of 36 issued patents with 38 patents pending. Through its research and development efforts, Nexxus Lighting is continually evaluating new intellectual property ideas that have the potential to be incorporated into advanced solid-state light bulbs, lighting fixtures and control systems.

Nexxus Lighting is a leader in advanced lighting technology, including solid-state LED and fiber optic lighting systems and controls used in commercial, architectural, signage, swimming pool, entertainment and retail lighting. Nexxus Lighting sells its products through its Commercial Lighting, Lumificient and Nexxus Lighting Pool & Spa divisions under the Array™ Lighting, Savi®, eLum™, LiveLED™, Super Vision® and Lumificient™ brand names.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.